close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Strona główna・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

15.08 1.75

Buy

Price update 2 sty 2026, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

14.81

Max

15.11

Key metrics

By Trading Economics

Income

28M

8.2M

Sales

351K

351K

P/E

Sector Avg

16.955

88.032

EPS

0.94

Profit margin

2,337.322

Employees

103

EBITDA

28M

9.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+45.21% upside

Market Stats

By TradingEconomics

Market Cap

1.6M

135M

Previous open

13.33

Previous close

15.08

News Sentiment

By Acuity

34%

66%

71 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 sty 2026, 22:45 UTC

Major Market Movers

GH Research Shares Up, Plans to Provide Update on New Drug Application

DJ

Read

4 sty 2026, 23:50 UTC

Market Talk
Major News Events

Gold Rises Amid Geopolitical Risks After Maduro's Ouster -- Market Talk

DJ

Read

4 sty 2026, 23:50 UTC

Market Talk
Major News Events

Nikkei May Decline After Removal of Venezuela's Maduro -- Market Talk

DJ

Read

4 sty 2026, 23:41 UTC

Market Talk
Major News Events

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

4 sty 2026, 23:40 UTC

Market Talk
Major News Events

Markets Mostly Calm as Venezuelan Raid Weighed -- Market Talk

DJ

Read

4 sty 2026, 23:35 UTC

Market Talk
Major News Events

Oil Declines on Oversupply Worries After Maduro's Ouster -- Market Talk

DJ

Read

4 sty 2026, 23:19 UTC

Market Talk
Major News Events

Global Energy Roundup: Market Talk

DJ

Read

4 sty 2026, 23:19 UTC

Market Talk
Major News Events

ONGC Could Receive $500M in Unpaid Dividends From U.S. Takeover of Venezuelan Oil -- Market Talk

DJ

Read

4 sty 2026, 23:17 UTC

Major News Events

Spot Gold Rises 0.8% to $4,365.24/oz

DJ

Read

4 sty 2026, 23:16 UTC

Major News Events

Spot Gold Rises After U.S.' Removal of Venezuela's Maduro

DJ

Read

4 sty 2026, 23:14 UTC

Major News Events

Front-Month WTI Crude Oil Futures Fall 0.6%; Front-Month Brent Crude Oil Futures Drop 0.5%

DJ

Read

4 sty 2026, 23:13 UTC

Major News Events

Front-Month Crude Oil Futures Fall After Ouster of Venezuela's Maduro

DJ

Read

4 sty 2026, 23:12 UTC

Market Talk
Major News Events

Reliance Industries' Could Benefit from U.S. Takeover of Venezuelan Oil -- Market Talk

DJ

Read

4 sty 2026, 22:37 UTC

Market Talk
Major News Events

Gold Can Gain From Flight to Quality, Central Bank Demand After Maduro Ouster -- Market Talk

DJ

Read

4 sty 2026, 21:00 UTC

Earnings

An On-Time Jobs Report. Plus, Albertsons, Constellation, Jefferies, and More Stocks to Watch this Week. -- Barrons.com

DJ

Read

4 sty 2026, 20:49 UTC

Market Talk
Major News Events

Global Energy Roundup: Market Talk

DJ

Read

4 sty 2026, 20:49 UTC

Market Talk
Major News Events

Jitters About Potential for U.S. Actions Elsewhere Could Grow -- Market Talk

DJ

Read

3 sty 2026, 18:59 UTC

Major News Events

Update: Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

DJ

Read

3 sty 2026, 17:42 UTC

Major News Events

The Oil Sector's Biggest Winners and Losers From Venezuela Regime Change -- Barrons.com

DJ

Read

3 sty 2026, 17:40 UTC

Major News Events

Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

DJ

Read

3 sty 2026, 16:10 UTC

Major News Events

What Maduro's Capture Means for Chevron Stock -- Barrons.com

DJ

Read

3 sty 2026, 15:53 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

DJ

Read

3 sty 2026, 15:03 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

DJ

Read

3 sty 2026, 14:10 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

DJ

Read

3 sty 2026, 12:16 UTC

Major News Events

U.S. Captures Maduro, Trump Says -- Barrons.com

DJ

Read

3 sty 2026, 09:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

3 sty 2026, 09:20 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

DJ

Read

3 sty 2026, 00:43 UTC

Acquisitions, Mergers, Takeovers

Research Reports -- Barrons.com

DJ

Read

2 sty 2026, 22:13 UTC

Market Talk
Earnings

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

DJ

Read

2 sty 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

45.21% upside

12 Months Forecast

Average 22 USD  45.21%

High 22 USD

Low 22 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

71 / 374 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

95.97

↓-0.18%

A

Agilent Technologies Inc

137.66

↑ +1.08%

VEEV

Veeva Systems Inc

219.44

↓-1.64%

HQY

HealthEquity Inc

91.05

↓-0.5%

PHR.US

Phreesia Inc

16.26

↓-3.79%
help-icon Live chat